Skip to main content
Cardinal Health, Inc. (CAH)
NYSE: CAH · Real-Time Price · USD
127.06
-0.32 (-0.25%)
Feb 21, 2025, 4:00 PM EST - Market closed

Cardinal Health Revenue by Segment
Period Ending Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017Sep 30, 2017Jun 30, 2017Mar 31, 2017Dec 31, 2016Sep 30, 2016
Pharmaceutical
205.05B 207.77B 210.79B 204.88B 201.03B 195.19B 190.01B 183.65B
Pharmaceutical Growth
2.00% 6.45% 10.93% 11.56% 13.07% 13.81% 14.82% 14.42%
Medical
12.55B 13.27B 13.91B 14.56B 15.13B 15.00B 15.01B 15.03B
Medical Growth
-17.07% -11.49% -7.35% -3.14% -0.66% -3.35% -5.50% -8.16%

Profit Margin by Segment
Period Ending Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017Sep 30, 2017Jun 30, 2017Mar 31, 2017Dec 31, 2016Sep 30, 2016
Pharmaceutical
1.04% 1.10% 0.87% 1.15% 0.97% 0.99% 1.01% 1.28%
Medical
0.56% 0.26% 1.51% 0.64% 1.81% 1.89% 2.18% 0.54%

Profit by Segment
Period Ending Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017Sep 30, 2017Jun 30, 2017Mar 31, 2017Dec 31, 2016Sep 30, 2016
Pharmaceutical
2.12B 2.11B 2.09B 2.11B 2.13B 2.08B 2.00B 1.95B
Pharmaceutical Growth
-0.28% 1.69% 4.40% 8.38% 16.15% 15.60% 12.94% 16.04%
Medical
93.00M 146.00M 209.00M 244.00M 244.00M 190.00M 111.00M 13.00M
Medical Growth
-61.89% -23.16% 88.29% 1,776.92% 369.23% 123.53% -48.61% -92.31%

Operating Expense Breakdown
Period Ending Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017Sep 30, 2017Jun 30, 2017Mar 31, 2017Dec 31, 2016Sep 30, 2016
Distribution, Selling, General, and Administrative
5.14B 5.12B 5.04B 5.03B 4.93B 4.83B 4.83B 4.72B
Distribution, Selling, General, and Administrative Growth
4.38% 5.90% 4.24% 6.50% 5.26% 4.18% 6.08% 4.22%
Amortization and Other Acquisition-Related Costs
336.00M 294.00M 284.00M 276.00M 270.00M 278.00M 285.00M 303.00M
Amortization and Other Acquisition-Related Costs Growth
24.44% 5.76% -0.35% -8.91% -12.34% -12.03% -12.04% -11.66%
Restructuring and Employee Severance
155.00M 174.00M 175.00M 139.00M 102.00M 91.00M 95.00M 107.00M
Restructuring and Employee Severance Growth
51.96% 91.21% 84.21% 29.91% -16.39% -18.75% -5.94% 20.22%
Impairments and (Gain)/Loss on Disposal of Assets, Net
94.00M 92.00M 630.00M 989.00M 925.00M 1.63B 1.25B 1.17B
Impairments and (Gain)/Loss on Disposal of Assets, Net Growth
-89.84% -94.37% -49.60% -15.40% -42.90% -25.90% -39.02% -33.77%
Litigation Charges, Net
60.00M 80.00M 79.00M -17.00M -174.00M -370.00M -302.00M -260.00M
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.